FDA Approval Summary: Selumetinib for Plexiform Neurofibroma

Casey, D; Demko, S; Sinha, A; Mishra-Kalyani, PS; Shen, YL; Khasar, S; Goheer, MA; Helms, WS; Pan, LL; Xu, Y; Fan, JH; Leong, R; Liu, J; Yang, YC; Windsor, K; Ou, M; Stephens, O; Oh, B; Reaman, GH; Nair, A; Shord, SS; Bhatnagar, V; Daniels, SR; Sickafuse, S; Goldberg, KB; Theoret, MR; Pazdur, R; Singh, H

Singh, H (corresponding author), FDA, Off Oncol Dis, Silver Spring, MD 20993 USA.

CLINICAL CANCER RESEARCH, 2021; 27 (15): 4142

Abstract

On April 10, 2020, the FDA approved selumetinib (KOSELUGO, AstraZeneca) for the treatment of pediatric patients 2 years of age and older with neurofib......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索